Weil, Gotshal & Manges LLP

New York, NY Professional servicesNAICS 541110

Self-funded health planPlan year 2025Renews January
1,819Participants+1% vs. prior year
$4.3MEst. pharmacy spend / yrParticipants × national avg.
Jan 2027Next renewalPlan year begins January 1
#21 of 70Professional services in NYBy participants

Overview

Weil, Gotshal & Manges LLP sponsors a self-funded health plan that covered 1,819 participants in plan year 2025, about the same as the prior year. The plan year starts in January. Alongside medical, its benefits filing reports life insurance, dental, vision, short-term disability, and more.

Plan type
ERISA welfare benefit plan, self-funded (benefits paid from employer assets or a trust)
Participants
1,819 · prior year 1,807
Plan year
Begins January 1 · next renewal January 2027
Health plans filed
Weil, Gotshal & Manges LLP Group Benefits Plan, plan 503 (1,819 participants)
Stop-loss carrier
United Healthcare Insurance Company of New York
Broker compensation
$283K across insured contracts
MedicalLife insuranceDentalVisionShort-term disabilityLong-term disabilityOther welfare benefits

Insurance carriers

Insured coverage reported on Schedule A. Self-funded medical claims aren't reported there.

CarrierCoverageCoveredPremiumBroker comp
Metropolitan Life Insurance CompanyLife, Short-term disability, Long-term disability1,444$5.4M$242K
United Healthcare Insurance Company of New YorkVision, Stop-loss3,048$1.4M—
Cigna Health and Life Insurance CompanyMedical, Dental26$513K$41K
Kaiser Foundation Health Plan Inc.Medical, Prescription drug, HMO43$355K—

Pharmacy benefit estimate

StreamRX estimate for a plan this size. Not based on this plan's claims.

$4.3M/ year

Estimated prescription spend: 1,819 participants × $2,371 national average per member. Usually higher once dependents are counted.

$112K–$276K/ year

Typical savings opportunity found in independent reviews of plans this size.

Brands with a generic available$33K–$82K
Lower-cost therapeutic alternatives$48K–$100K
Generic pricing vs. actual cost$21K–$62K
PBM contract terms$11K–$32K
The DOL's PBM fee disclosure rule first applies to this plan for the plan year beginning January 2028: semiannual PBM compensation reports and an annual audit right.

Form 5500 filing details

Filing
Form 5500 with Schedule A, plan year 2025
Plan sponsor
Weil, Gotshal & Manges LLP
Sponsor EIN
13-1456110
Plan number
503
Filed with
U.S. Department of Labor (EBSA) via EFAST2

Verify this filing: search EIN 13-1456110 in the Department of Labor's EFAST2 Form 5500 search.

Retirement plan

Plan
Weil, Gotshal & Manges Section 401(k) Savings and Investment Plan
Type
401(k) plan
Participants
2,914

About this data

Source: Weil, Gotshal & Manges LLP's Form 5500 filing for plan year 2025 and its Schedule A insurance reports, published by the U.S. Department of Labor. "Self-funded" means the filing reports benefits paid from employer assets or a trust, with no medical insurance contract or with a stop-loss contract. Pharmacy figures are StreamRX estimates based on national averages. StreamRX is not affiliated with Weil, Gotshal & Manges LLP.

Request a correction · Methodology